Because of clinical utility, immediate feedback, absence of risk to the patient, portability, and use in virtually any practice setting, facilities using thoracic electrical bioimpedance monitoring are increasing throughout the world. Specialized centers treating patients with heart failure have shown remarkable benefits, both in health care costs and patient morbidity, attributable to the careful monitoring and management of patients with heart failure. The ability of thoracic bioimpedance monitoring to provide objective data in the management of congestive heart failure provides practitioners with the clinical reassurance to optimize pharmacologic therapy safely.
Skip Nav Destination
Noninvasive Monitoring Using Thoracic Bioimpedance| August 01 1999
Managing Congestive Heart Failure With Thoracic Electrical Bioimpedance
Joanne Gilbert, RN, CCRC;
*From Pacific Heart Center, Santa Monica, California
Reprint requests to: Joanne Gilbert, RN, CCRC, Senior Clinical Research Coordinator, Cardiovascular Nurse, Pacific Heart Institute, 2001 Santa Monica Blvd., 280 West, Santa Monica, CA 90404.
Search for other works by this author on:
AACN Adv Crit Care (1999) 10 (3): 400–405.
- Views Icon Views
- Share Icon Share
Joanne Gilbert, Lucin Lazio; Managing Congestive Heart Failure With Thoracic Electrical Bioimpedance. AACN Adv Crit Care 1 August 1999; 10 (3): 400–405. doi:
Download citation file: